Controversial US-backed vaccine trial in African newborns halted
A US-backed hepatitis B vaccine trial in African newborns was halted after drawing global backlash, the lead researcher said on Wednesday. The study was to be funded with $1.6 million from the US Centers for Disease Control and Prevention and another $1.6 million from private partners.